凯发k8一触即发
About Us
凯发k8一触即发:About Sino Biopharm
凯发k8一触即发:Board of Directors
凯发k8一触即发:Senior Management
凯发k8一触即发:R&D
R&D Team
凯发k8一触即发:Products
凯发k8一触即发:Product List
凯发k8一触即发:Sustainability
凯发k8一触即发:ESG Governance
凯发k8一触即发:ESG Management Practices
凯发k8一触即发:ESG Reports
凯发k8一触即发:Investors
凯发k8一触即发:Information Disclosure
凯发k8一触即发:Corporate Governance
凯发k8一触即发:Presentation
凯发k8一触即发:Investor FAQ
Notices
凯发k8一触即发:News
凯发k8一触即发:Press Releases
凯发k8一触即发:Contact
CN
EN
Investors
Home
>
凯发k8一触即发:Investors
>
Notices
凯发k8一触即发:
Information Disclosure
凯发k8一触即发:
Corporate Governance
凯发k8一触即发:
Presentation
凯发k8一触即发:
Investor FAQ
Notices
Notices
Replacement of Lost Share Certificates
Notice of Cancellation of Original Share Certificate and Issue of New Certificate
2025.03.06
Notice of Intention to Issue New Share Certificate
2024.11.22